Strong Industry Recognition Delfina has received prestigious awards such as the Best Maternal Health Platform at the MedTech Breakthrough Awards, highlighting its credibility and innovative leadership in maternal health technology, making it an attractive partner for healthcare organizations seeking advanced digital health solutions.

Strategic Partnership Opportunities Recent collaborations with major healthcare payers like UnitedHealthcare demonstrate Delfina’s ability to integrate into large healthcare networks, presenting opportunities to expand partnerships with health insurers and care providers focused on pregnancy and maternal health.

Robust Funding and Growth With $17 million raised in Series A funding led by top investors including US Venture Partners and Mayo Clinic, Delfina is positioned for growth and innovation, making it a compelling candidate for additional strategic investments or enterprise collaborations.

Focus on AI-Driven Care Delfina’s AI-powered prenatal care system aligns with emerging trends in digital health and personalized medicine, offering sales prospects with hospitals, clinics, and health systems aiming to leverage advanced technology for improved maternal health outcomes.

Targeted Market Segment Operating in the hospital and healthcare industry with revenues between $50 million and $100 million, Delfina presents opportunities to partner with mid-sized to large healthcare providers seeking innovative solutions to reduce pregnancy complications and improve patient engagement.